Cannabis – a dangerous drug or a miraculous medication?
Abstract
Downloads
References
Ferjan I, Kržan M, Lipnik-Štangelj M, Žiberna L, Stanovnik L, Černe K. Farmakologija kanabinoidov. Zdrav Vestn 2015; 84: 456–71.
Červek J, Červek M., Možnosti zdravljenja maligne bolezni s kanabinoidi, v Onkologija–tarčna zdravila 2015. Lekarniška zbornica. Zbornik strokovnega izobraževanja za magistre farmacije v letu 2015, str. 145–154.
Krek Milan, Dvodnevni kongres študentov medicine, organizator Medicinski fakulteti v Ljubljani, maj 2015.
Nolimal, D., Ali strah pred medicinsko konopljo res hromi zdravnike?, ISIS (v tisku)
Chakravarti B., Cannabinoids as therapeutic agents in cancer: current status and future implications, Oncotarget 2014 ; 5: 5852–72.
Ramer R., Hinz B., New insights into antimetastatic and antiangiogenic effects of cannabinoids, Int Rev Cell Mol Biol. 2015; 314: 43–116
Cohen, PJ., Medical marijuana: the conflict between scientific evidence and political ideology, J Pain Palliat Care Pharmacother. 2009; 23: 120–40.
Strouse t., Pot in Palliative Care: What We Need to Know, Journal of Palliative Medicine. Journal of Palliative Medicine. January 2015, 18: 7–10.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
